Table 1 Results of cost utility analyses under scenario A
New Drug | Standard of Care | Increment | |
|---|---|---|---|
a. Treatment of a Patient’s Rare Disease | |||
QALYs | 4.45 | 4.2 | 0.25 |
Weighted QALYs | 8.9 | 8.4 | 0.5 |
Costs | $42,000 | $19,000 | $23,000 |
Incremental cost per QALY gained | $92,000 | ||
Incremental cost per weighted QALY gained | $46,000 | ||
b. Treatment of a Patient’s Co-morbidity | |||
QALYs | 4.5 | 4.2 | 0.3 |
Weighted QALYs | 4.5 | 4.2 | 0.3 |
Costs | $33.550 | $19,000 | $14,550 |
Incremental cost per QALY gained | $48,500 | ||
Incremental cost per weighted QALY gained | $48,500 | ||